Stefano Gentileschi

Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study

Claudia Fabiani, Antonio Vitale, Giacomo Emmi et al. · Clinical Rheumatology · 2016 · 141 citations

Life Sciences, Immunology, Ophthalmology +16

A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study

Antonio Vitale, Antonella Insalaco, Paolo Sfriso et al. · Frontiers in Pharmacology · 2016 · 88 citations · Full text

Medicine, Immunology, Pharmacotherapy +12

Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study

Jurgen Sota, Antonio Vitale, Antonella Insalaco et al. · Clinical Rheumatology · 2018 · 82 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients

Claudia Fabiani, Antonio Vitale, Donato Rigante et al. · Clinical Rheumatology · 2018 · 67 citations

Medicine, Immunology, Pharmacotherapy +17

Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study

Antonio Vitale, Giacomo Emmi, Giuseppe Lopalco et al. · Clinical Rheumatology · 2016 · 54 citations

Life Sciences, Clinical Sciences, Immunology +12